Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
OrbiMed’s $50 Million Financing
Marsh & McLennan Agency’s $345 Million Acquisition of Fisher Brown Bottrell Insurance
Covington & Burling and Brunini, Grantham, Grower & Hewes advised Trustmark National Bank on the transaction. Marsh McLennan Agency, a subsidiary of Marsh, announced that it...
OrbiMed’s $125 Million Debt Financing
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
DRI Healthcare Trust’s $85 Million of Royalty Interest in Breast Cancer Treatment
Covington advised Eisai in the transaction. Eisai Co., Ltd. signed its agreement to transfer all future economic rights for elacestrant (generic name), approved for the treatment for...
Caris Life Sciences’ $400 Million Secured Debt Financing
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
Insmed Incorporated’s $775 Million Financing
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...